Matrix metalloproteinases (
MMPs) are a family of important
proteolytic enzymes that play an important role in the remodeling of the tumor microenvironment and associate with
tumorigenesis and
metastasis. We previously reported that membrane type-2
MMP (MT2-MMP) is highly expressed in human
esophageal cancer tissues, and its expression level is positively correlated to
tumor size and intratumoral angiogenesis. In order to reveal whether
MT2-MMP expression is operative in human
lung cancer and its underlying physio-pathological role, in the present study, we examined both
mRNA and
protein expression levels of
MT2-MMP in non-small cell lung caner (NSCLC) tissues and in adjacent normal tissues by using real-time RT-PCR and immunohistochemistry respectively, which showed that both
MT2-MMP mRNA (P=0.0359) and
protein (P<0.0001) expression levels were significantly increased in
cancer tissues in contrast to adjacent normal tissues. Moreover, we also found that the
MT2-MMP protein level in
cancer tissues positively correlated to
lymph node metastasis (P=0.0483),
tumor stage (P=0.0483), intra-tumoral microvessel density (MVD) (P=0.0445). We have not found statistically significant correlation between
MT2-MMP expression and patients' prognoses, but we found that the patients with both higher
MT2-MMP protein expression and higher intra-tumoral microvessel density showed better prognoses than that of the patients with either higher
MT2-MMP protein expression or higher intra-tumoral microvessel density (P=0.0311). Thus, our data suggest that
MT2-MMP expression positively involves in NSCLC, and might play an important role in promoting the
tumor progression and intra-tumoral angiogenesis in NSCLC.